CHAPTER 1 INTRODUCTION

1.1 Report description
1.1 Key benefits
1.2 Key market segment
1.3 Research methodology

1.3.1 Secondary research
1.3.2 Primary research
1.3.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO perspective

CHAPTER 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top winning strategies

3.3 Conventional pathology vs. digital pathology
3.4 Key player positioning, 2015
3.5 Market dynamics

3.5.1 Drivers

3.5.1.1 Use of digital pathology in cancer diagnosis
3.5.1.2 Cost efficiency
3.5.1.3 Ease in transportation
3.5.1.4 High efficiency
3.5.1.5 Efficient analysis
3.5.1.6 System efficiency
3.5.1.7 Efficiency in workflow
3.5.1.8 Diagnosis in remote regions

3.5.2 Restraints

3.5.2.1 Lack of reimbursement
3.5.2.2 Lack of infrastructure in developing economies
3.5.2.3 Resistance towards adoption of digital pathology

3.5.3 Opportunities

3.5.3.1 Rising awareness pertaining to digital pathology
3.5.3.2 Increasing potential of digital pathology

CHAPTER 4 GERMANY DIGITAL PATHOLOGY MARKET, BY PRODUCT

4.1 Overview

4.1.1 Market size and forecast
4.1.2 Whole slide imaging (WSI)

4.1.2.1 Market size and forecast

4.1.3 Image analysis informatics

4.1.3.1 Market size and forecast

4.1.4 Information management system storage & communication

4.1.4.1 Market size and forecast

4.1.5 Telepathology

4.1.5.1 Market size and forecast

CHAPTER 5 GERMANY DIGITAL PATHOLOGY MARKET, BY END USER

5.1 Overview

5.1.1 Market size and forecast
5.1.2 Educational institutes

5.1.2.1 Market size and forecast

5.1.3 Hospitals and diagnostic centers

5.1.3.1 Market size and forecast

5.1.4 Pharmaceutical and biotechnology companies

5.1.4.1 Market size and forecast

CHAPTER 6 COMPANY PROFILES

6.1 Danaher Corporation (Leica Microsystem)

6.1.1 Company Overview
6.1.2 Company Snapshot
6.1.3 Operating Business Segments
6.1.4 Business Performance
6.1.5 Key Strategic Moves & Developments

6.2 Definiens AG

6.2.1 Company Overview
6.2.2 Company Snapshot
6.2.3 Business Performance
6.2.4 Key Strategic Moves & Developments

6.3 Carl Zeiss AG

6.3.1 Company Overview
6.3.2 Company Snapshot
6.3.3 Operating Business Segments
6.3.4 Business Performance
6.3.5 Key Strategic Moves and Developments

6.4 VMscope GmbH

6.4.1 Company Overview
6.4.2 Company Snapshot
6.4.3 Operating Business Segments
6.4.4 Business Performance
6.4.5 Key Strategic Moves and Developments

6.5 microDimensions GmbH

6.5.1 Company Overview
6.5.2 Company Snapshot
6.5.3 Operating Business Segments
6.5.4 Business Performance
6.5.5 Key Strategic Moves and Developments

6.6 Visiopharm

6.6.1 Company Overview
6.6.2 Company Snapshot
6.6.3 Operating Business Segments
6.6.4 Business Performance
6.6.5 Key Strategic Moves & Developments

6.7 Koninklijke Philips N.V.

6.7.1 Company Overview
6.7.2 Company Snapshot
6.7.3 Operating Business Segments
6.7.4 Business Performance
6.7.5 Key Strategic Moves & Developments

6.8 PerkinElmer, Inc.

6.8.1 Company Overview
6.8.2 Company Snapshot
6.8.3 Operating Business Segments
6.8.4 Business Performance
6.8.5 Key Strategic Moves & Developments

6.9 Nikon Corporation

6.9.1 Company Overview
6.9.2 Company Snapshot
6.9.3 Operating Business Segments
6.9.4 Business Performance
6.9.5 Key Strategic Moves & Developments

6.10 Digipath, Inc.

6.10.1 Company Overview
6.10.2 Company Snapshot
6.10.3 Operating Business Segments
6.10.4 Key Strategic Moves & Developments

Other players in the value chain include:

Indica Labs
Hamamatsu Photonics Europe GmbH
Pixcelldata Ltd.
Glencoe Software Inc.

*Profiles of these players are not included. The same will be included on request.